Back to list
30 November 2015

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up

Federico Mosna from Department of Hematology, General Hospital, Treviso, Italy - June 2015 - American Journal of Hematology. Correspondence to: Giovanni Martinelli, MD, Department of Hematology, Ist "LA Seragnoli," University of Bologna, Via Massarenti 9, Bologna, 40138 Italy. E-mail: Contract grant sponsor: AIL (TREVISO-BOLOGNA), ELN, AIRC, PRIN, FP7 NGS-PTL project. Received for publication: 22 January 2015; Revised: 27 February 2015; Accepted: 2 March 2015 Am. J. Hematol. 90